Tandlægeselskabet Colosseum Sønderborg ApS — Credit Rating and Financial Key Figures
CVR number: 41343354
Perlegade 30 A, 6400 Sønderborg
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 1 715.47 | 7 966.60 | 7 995.89 | 9 124.47 |
| Employee benefit expenses | -1 968.59 | -6 704.64 | -7 220.58 | -7 526.18 |
| Total depreciation | - 156.30 | - 513.94 | - 492.64 | - 561.58 |
| EBIT | - 409.42 | 748.02 | 282.67 | 1 036.71 |
| Other financial income | 6.18 | 3.06 | 3.66 | 9.62 |
| Other financial expenses | -42.55 | -88.98 | -67.61 | -33.30 |
| Pre-tax profit | - 445.79 | 662.10 | 218.71 | 1 013.04 |
| Income taxes | -48.00 | -56.54 | - 286.00 | |
| Net earnings | - 445.79 | 614.10 | 162.18 | 727.04 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Buildings | 79.25 | 63.40 | 47.59 | |
| Machinery and equipment | 1 557.84 | 1 577.52 | 1 137.14 | 601.77 |
| Tangible assets total | 1 557.84 | 1 656.77 | 1 200.54 | 649.36 |
| Investments total | ||||
| Long term receivables total | ||||
| Raw materials and consumables | 166.34 | 128.59 | 120.00 | |
| Finished products/goods | 94.80 | |||
| Inventories total | 94.80 | 166.34 | 128.59 | 120.00 |
| Current trade debtors | 270.63 | 261.50 | 284.75 | 324.58 |
| Prepayments and accrued income | 89.82 | 173.99 | 92.66 | 82.74 |
| Current other receivables | 805.56 | 475.95 | 511.13 | 1 222.71 |
| Short term receivables total | 1 166.00 | 911.44 | 888.55 | 1 630.04 |
| Cash and bank deposits | 1 315.00 | 1 457.34 | 192.15 | 34.01 |
| Cash and cash equivalents | 1 315.00 | 1 457.34 | 192.15 | 34.01 |
| Balance sheet total (assets) | 4 133.64 | 4 191.88 | 2 409.83 | 2 433.41 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 330.49 | 727.04 | ||
| Retained earnings | - 445.79 | - 162.18 | - 727.04 | |
| Profit of the financial year | - 445.79 | 614.10 | 162.18 | 727.04 |
| Shareholders equity total | - 405.79 | 208.31 | 370.49 | 767.04 |
| Provisions | 218.13 | |||
| Non-current owed to participating | 1 161.67 | 821.67 | ||
| Non-current other liabilities | 432.19 | |||
| Non-current deferred tax liabilities | 65.13 | |||
| Non-current liabilities total | 1 161.67 | 821.67 | 65.13 | 432.19 |
| Advances received | 18.20 | 4.25 | 7.73 | 9.50 |
| Current trade creditors | 293.09 | 707.75 | 134.66 | 183.15 |
| Current owed to participating | 908.78 | 787.29 | ||
| Short-term deferred tax liabilities | 48.00 | 75.74 | 239.54 | |
| Other non-interest bearing current liabilities | 2 157.69 | 1 614.60 | 1 537.95 | 801.98 |
| Current liabilities total | 3 377.75 | 3 161.89 | 1 756.08 | 1 234.17 |
| Balance sheet total (liabilities) | 4 133.64 | 4 191.88 | 2 409.83 | 2 433.41 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.